The quality-adjusted life-year (QALY) is a health metric some people love to hate. Concerns include that QALYs are not patient focused,1 may be used as rationing tools by health insurers, and may be perceived as dehumanizing. The Affordable Care Act prohibits the Patient-Centered Outcomes Research Institute from using cost-per-QALY benchmarks. The use of QALYs by policy makers to inform coverage and reimbursement decisions is controversial.
Neumann PJ, Cohen JT. QALYs in 2018—Advantages and Concerns. JAMA. 2018;319(24):2473–2474. doi:10.1001/jama.2018.6072
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.